Forbes And Company Share Price
Sector: Healthcare Facilities
375.55 -5.55 (-1.46%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
373.50
Today’s High
375.55
52 Week Low
264.35
52 Week High
787.95
Key Metrics
- Market Cap (In Cr) 484.4
- Beta 0.4
- Div. Yield (%) 0
- P/B 2.24
- TTM P/E 13.49
- Peg Ratio -
- Sector P/E 16.29
- D/E 0
- Open Price 373.5
- Prev Close 381.1
Forbes And Company Analysis
Price Analysis
-
1 Week6.05%
-
3 Months24.62%
-
6 Month-27.21%
-
YTD-18.52%
-
1 Year-42.14%
Risk Meter
- 52% Low risk
- 52% Moderate risk
- 52% Balanced Risk
- 52% High risk
- 52% Extreme risk
Forbes And Company News
Adani Power, Tata Tech, Vedanta to PNB — 82 firms to declare Q3 results today
4 min read . 25 Jan 2024Multibagger stock announces ₹65 special interim dividend. Check record date
1 min read . 18 Aug 2022Major cosmetics company Revlon set to file for bankruptcy amid heavy debt load
1 min read . 11 Jun 2022Forbes And Company Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 199.23
- Selling/ General/ Admin Expenses Total
- 14.26
- Depreciation/ Amortization
- 1.58
- Other Operating Expenses Total
- 17.25
- Total Operating Expense
- 173.1
- Operating Income
- 26.13
- Net Income Before Taxes
- 40.22
- Net Income
- 122.76
- Diluted Normalized EPS
- 22.72
- Period
- 2025
- Total Assets
- 304.78
- Total Liabilities
- 85.3
- Total Equity
- 219.48
- Tangible Book Valueper Share Common Eq
- 170.15
- Period
- 2025
- Cashfrom Operating Activities
- -11.13
- Cashfrom Investing Activities
- 6.5
- Cashfrom Financing Activities
- -0.64
- Net Changein Cash
- -5.27
- Period
- 2024
- Total Revenue
- 125.9
- Selling/ General/ Admin Expenses Total
- 31.79
- Depreciation/ Amortization
- 1.02
- Other Operating Expenses Total
- 2.59
- Total Operating Expense
- 126.02
- Operating Income
- -0.12
- Net Income Before Taxes
- 21.38
- Net Income
- -4.46
- Diluted Normalized EPS
- 4.4
- Period
- 2024
- Total Assets
- 420.65
- Total Liabilities
- 280.37
- Total Equity
- 140.28
- Tangible Book Valueper Share Common Eq
- 108.71
- Period
- 2024
- Cashfrom Operating Activities
- -27.26
- Cashfrom Investing Activities
- 7.85
- Cashfrom Financing Activities
- -6.46
- Net Changein Cash
- -25.88
- Period
- 2023
- Total Revenue
- 441.98
- Selling/ General/ Admin Expenses Total
- 232.77
- Depreciation/ Amortization
- 26.58
- Other Operating Expenses Total
- 37.94
- Total Operating Expense
- 467.39
- Operating Income
- -25.41
- Net Income Before Taxes
- 219.12
- Net Income
- 191.95
- Diluted Normalized EPS
- 32.45
- Period
- 2023
- Total Assets
- 701.1
- Total Liabilities
- 476.28
- Total Equity
- 224.81
- Tangible Book Valueper Share Common Eq
- 168.55
- Period
- 2023
- Cashfrom Operating Activities
- 54.22
- Cashfrom Investing Activities
- 215.95
- Cashfrom Financing Activities
- -242.81
- Net Changein Cash
- 27.35
- Period
- 2022
- Total Revenue
- 514.73
- Selling/ General/ Admin Expenses Total
- 256.63
- Depreciation/ Amortization
- 40.8
- Other Operating Expenses Total
- 13.16
- Total Operating Expense
- 846.5
- Operating Income
- -331.77
- Net Income Before Taxes
- -333.9
- Net Income
- 4229.7
- Diluted Normalized EPS
- -78.36
- Period
- 2022
- Total Assets
- 797.16
- Total Liabilities
- 714.58
- Total Equity
- 82.58
- Tangible Book Valueper Share Common Eq
- 48.43
- Period
- 2022
- Cashfrom Operating Activities
- 177.64
- Cashfrom Investing Activities
- 32.11
- Cashfrom Financing Activities
- -275.12
- Net Changein Cash
- -65.37
- Period
- 2021
- Total Revenue
- 932.42
- Selling/ General/ Admin Expenses Total
- 300.01
- Depreciation/ Amortization
- 67.48
- Other Operating Expenses Total
- 45.59
- Total Operating Expense
- 911.66
- Operating Income
- 20.77
- Net Income Before Taxes
- -29.94
- Net Income
- -77.67
- Diluted Normalized EPS
- 2.97
- Period
- 2021
- Total Assets
- 2042.88
- Total Liabilities
- 2183.91
- Total Equity
- -141.02
- Tangible Book Valueper Share Common Eq
- -370.55
- Period
- 2021
- Cashfrom Operating Activities
- 353.97
- Cashfrom Investing Activities
- 77.06
- Cashfrom Financing Activities
- -381.73
- Net Changein Cash
- 49.06
- Period
- 2020
- Total Revenue
- 2730.79
- Selling/ General/ Admin Expenses Total
- 1539.81
- Depreciation/ Amortization
- 97.45
- Other Operating Expenses Total
- 89.5
- Total Operating Expense
- 3009.87
- Operating Income
- -279.08
- Net Income Before Taxes
- -337.52
- Net Income
- -324.6
- Diluted Normalized EPS
- -145.12
- Period
- 2020
- Total Assets
- 2747.81
- Total Liabilities
- 2835.96
- Total Equity
- -88.15
- Tangible Book Valueper Share Common Eq
- -389.9
- Period
- 2020
- Cashfrom Operating Activities
- 229.41
- Cashfrom Investing Activities
- -143.12
- Cashfrom Financing Activities
- -122.34
- Net Changein Cash
- -36.03
- Period
- 2025-03-31
- Total Revenue
- 88.68
- Selling/ General/ Admin Expenses Total
- 3.2
- Depreciation/ Amortization
- 0.41
- Other Operating Expenses Total
- 4.96
- Total Operating Expense
- 74.79
- Operating Income
- 13.89
- Net Income Before Taxes
- 13.07
- Net Income
- 102.84
- Diluted Normalized EPS
- 5.99
- Period
- 2025-03-31
- Total Assets
- 304.78
- Total Liabilities
- 85.3
- Total Equity
- 219.48
- Tangible Book Valueper Share Common Eq
- 170.15
- Period
- 2025-03-31
- Cashfrom Operating Activities
- -11.13
- Cashfrom Investing Activities
- 6.5
- Cashfrom Financing Activities
- -0.64
- Net Changein Cash
- -5.27
- Period
- 2024-12-31
- Total Revenue
- 40.23
- Selling/ General/ Admin Expenses Total
- 3.79
- Depreciation/ Amortization
- 0.42
- Other Operating Expenses Total
- 5.7
- Total Operating Expense
- 37.17
- Operating Income
- 3.06
- Net Income Before Taxes
- 13.04
- Net Income
- 9.5
- Diluted Normalized EPS
- 7.46
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 34.66
- Selling/ General/ Admin Expenses Total
- 3.91
- Depreciation/ Amortization
- 0.37
- Other Operating Expenses Total
- 3.8
- Total Operating Expense
- 31.06
- Operating Income
- 3.6
- Net Income Before Taxes
- 6.24
- Net Income
- 5.14
- Diluted Normalized EPS
- 4.2
- Period
- 2024-09-30
- Total Assets
- 412.55
- Total Liabilities
- 228.28
- Total Equity
- 184.27
- Tangible Book Valueper Share Common Eq
- 142.84
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -16.07
- Cashfrom Investing Activities
- 8.71
- Cashfrom Financing Activities
- -0.31
- Net Changein Cash
- -7.67
- Period
- 2024-06-30
- Total Revenue
- 35.79
- Selling/ General/ Admin Expenses Total
- 3.63
- Depreciation/ Amortization
- 0.38
- Other Operating Expenses Total
- 3.57
- Total Operating Expense
- 31.38
- Operating Income
- 4.41
- Net Income Before Taxes
- 6.49
- Net Income
- 5.28
- Diluted Normalized EPS
- 4.15
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 125.9
- Selling/ General/ Admin Expenses Total
- 14.96
- Depreciation/ Amortization
- 1.64
- Other Operating Expenses Total
- 20.76
- Total Operating Expense
- 126.02
- Operating Income
- -0.12
- Net Income Before Taxes
- 21.38
- Net Income
- -4.46
- Diluted Normalized EPS
- 16.95
- Period
- 2024-03-31
- Period
- 2024-03-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Forbes And Company Technical
Moving Average
SMA
- 5 Day366.65
- 10 Day362.08
- 20 Day360.13
- 50 Day327.21
- 100 Day363.82
- 300 Day490
Forbes And Company Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Gpt Healthcare
- 155
- -1.05
- -0.67
- 206.5
- 126.15
- 1280.34
- Kerala Ayurveda
- 420
- -14.1
- -3.25
- 486.9
- 250
- 505.36
- Forbes And Company
- 375.55
- -5.55
- -1.46
- 787.95
- 264.35
- 484.4
- Aashka Hospitals
- 96.9
- -0.1
- -0.1
- 126.55
- 65.26
- 226.75
- Lotus Eye Hospital And Institute
- 74.39
- 0.29
- 0.39
- 91
- 53
- 154.7
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Gpt Healthcare
- 26.57
- 5.94
- 21.36
- 10.33
- Kerala Ayurveda
- -
- 15.84
- -2.12
- 0.07
- Forbes And Company
- 17.12
- 2.29
- -36.13
- -7.89
- Aashka Hospitals
- 96.14
- 2.36
- 2.55
- 5.12
- Lotus Eye Hospital And Institute
- 52.62
- 2.58
- 4.65
- 6.09
Forbes And Company Shareholding
Shareholding Pattern
*Promoter pledging: 72.56%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 30-Apr-25
- Audited Results
- 11-Feb-25
- Quarterly Results
- 28-Oct-24
- Quarterly Results
- 02-Aug-24
- Quarterly Results
- 29-May-24
- Audited Results
- 25-Jan-24
- Quarterly Results
- 03-Nov-23
- Quarterly Results
- 10-Aug-23
- Quarterly Results
- 26-May-23
- Audited Results
- 02-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 02-Nov-24
- 30-Sept-24
- POM
- 29-Aug-24
- 07-Aug-24
- AGM
- 20-Mar-24
- 16-Feb-24
- POM
- 31-Oct-23
- 03-Oct-23
- COM
- 20-Sept-23
- 18-Aug-23
- POM
- 10-Aug-23
- 20-Jul-23
- AGM
- 26-Jun-22
- 25-May-22
- POM
- 13-Aug-21
- 12-Jul-21
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 16-Aug-22
- 25-Aug-22
- 24-Aug-22
- 65


